Miacalcin Solution For Injection 200U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Miacalcin: Solution for injection (200U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

CALCITONIN (kal si TOE nin) is a hormone. It helps control calcium in the body. It is used to treat Paget's disease, osteoporosis, and hypercalcemia.

In-Depth Information

Miacalcin 200unit/ml Solution for Injection

NDC: 000780149
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Osteoporosis, Paget's Disease, Hypercalcemia

Sometimes used for but not FDA approved for the following conditions:
Bone Pain, Bone Metastases, Neuropathic Pain, Diabetic Neuropathy

Storage Information
Refrigerate (between 36 and 46 degrees F)
Miacalcin 200unit/ml Solution for Injection

Reported Side Effects for Miacalcin 200unit/ml Solution for Injection

Kidney Stones Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Shaking Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Bundle-branch Block Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Blood In The Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Fluid Retention Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Brain Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Deafness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Flushing Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Causing To Be Hungry Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Metallic Taste Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Diaphoresis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Distressed Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hair Loss Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Weight Gain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Skin Ulcer Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Gallstones Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Bladder Infection Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Irritated Blood Vessels Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Migraine Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Overactive Thyroid Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Ear Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Enlarged Thyroid Gland Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Stomach Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Swelling Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Secretion Of Tears Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Enlarged Lymph Nodes Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: EARLY
Constipation Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: EARLY
Muscle Pain Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Breathing Difficulties Incidence:
1.0-3.0%*
Severity: SEVERE
Onset: RAPID
Conjunctivitis Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
1.8-10.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.8-10.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
3.2%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
3.8%*
Severity: MILD
Onset: DELAYED
Secondary Malignancy Incidence:
4.1%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Injection Site Reaction Incidence:
10.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Miacalcin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5